Bioerodible polymeric nanoparticles for targeted delivery of proteic drugs

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 3040-3047

  Chiellini, Elisabetta E ^a   Chiellini, Federica ^a   Solaro, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Albumin; Controlled Release; Coprecipitation; Interferon; Maleic Anhydride Alkyl Vinyl Ether Alternating Copolymers; Nanoparticles; Targeted Release

Indexed keywords

ALBUMIN; ALKYL VINYL ETHER; COPRECIPITATION; INTERFERON; MALEIC ANHYDRIDE; TARGETED RELEASE;

CELLS; COPOLYMERS; DRUG PRODUCTS; LIPIDS; NANOSTRUCTURED MATERIALS; PRECIPITATION (CHEMICAL); PROTEINS; SPECTROSCOPIC ANALYSIS;

CONTROLLED DRUG DELIVERY;

DRUG CARRIER; NANOMATERIAL; PROTEIN;

ANIMAL; ARTICLE; BIOREMEDIATION; CHEMISTRY; DRUG DELIVERY SYSTEM; EVALUATION; GUINEA PIG; HUMAN; LIVER CELL; MATERIALS TESTING; METABOLISM; METHODOLOGY; PARTICLE SIZE; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; BIODEGRADATION, ENVIRONMENTAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GUINEA PIGS; HEPATOCYTES; HUMANS; MATERIALS TESTING; NANOSTRUCTURES; PARTICLE SIZE; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33750065411     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.412     Document Type: Conference Paper

References (36)

1. S. M. Moghini, A. C. Hunter, and J. C. Murray, Pharmacol. Rev. 53, 283 (2001).
2. J. K. Vasir, M. K. Reddy, and V. D. Labhasetwar, Curr. Nanosci. 1, 47 (2005).
3. O. Kayser, A. Lemke, and N. Hernandez-Trejo, Curr. Pharm. Biotechnol. 6, 3 (2005).
4. M. R. Kumar, G. Hellermann, R. F. Lockey, and S. S. Mohapatra, Expert Opin. Biol. Th. 4, 1213 (2004).
5. J. Panyam and V. Labhasetwar, Curr. Drug Deliv. 1, 235 (2004).
6. Y. Nishioka and H. Yoshino, Adv. Drug Deliv. Rev. 47, 55 (2001).
7. C. Lemarchand, R. Gref, and P. Couvreur, Eur. J. Pharm. Biopharm. 58, 327 (2004).
8. S. V. Vinagradov, T. K. Bronich, and A. V. Kabanov, Adv. Drug. Deliv. Rev. 54, 223 (2002).
9. D. A. Wall, G. Wilson, and A. L. Hubbard, Cell 21, 79 (1980).
10. G. Ashwell and J. Harford, Ann. Rev. Biochem. 51, 531 (1982).
11. D. Bhadra, A. K. Yadav, S. Bhadra, and N. K. Jain, Int. J. Pharm. 295, 221 (2005).
12. E. Chiellini, E. E. Chiellini, F. Chiellini, and R. Solaro, ACS Polym. Prep., Div. Polym. Chem. 39, 182 (1998).
13. N. Tamburro, F. Chiellini, and R. Solaro, J. Bioact. Compat. Polym. 16, 77 (2001).
14. A. Ahluwalia, G. Basta, F. Chiellini, D. Ricci, and G. Vozzi, J. Mater. Sci: Mater. Med. 12, 613 (2001).
15. F. Chiellini, R. Bizzarri, C. K. Ober, D. Schmaljohann, T. Yu, R. Solaro, and E. Chiellini, Macromol. Rapid Commun. 22, 1284 (2001).
16. R. Bizzarri, F. Chiellini, R. Solaro, E. Chiellini, S. Gammas-Marion, and P. Guerin, Macromolecules 35, 1215 (2001).
17. R. Bizzarri, E. Chiellini, E. E. Chiellini, F. Chiellini, C. Fiumi, F. Signori, and R. Solaro, Chim. Ind. 83, 51 (2001).
18. E. Chiellini, E. E. Chiellini, F. Chiellini, and R. Solaro, J. Bioact. Compat. Polym. 16, 441 (2001).
19. F. Chiellini, F. Petrucci, E. Ranucci, and R. Solaro, J. Appl. Polym. Sci. 85, 2729 (2002).
20. R. Bizzarri, F. Chiellini, C. K. Ober, W. M. Saltzman, and R. Solaro, Macromol. Chem. Phys. 203, 1684 (2001).
21. R. Solaro, F. Chiellini, F. Signori, C. Fiumi, R. Bizzarri, and E. Chiellini, J. Mater. Sci.: Mater. Med. 14, 705 (2003).
22. A. Marayama, T. Ishihara, N. Adachi, and T. Akaike, Biomaterials 15, 1035 (1994).
23. E. Chiellini, R. Solaro, L. Bemporad, S. D'Antone, D. Giannasi, and G. Leonardi, J. Biomater. Sci. Polym. Ed. 7, 307 (1995).
24. R. Solaro, S. D'Antone, L. Bemporad, and E. Chiellini, J. Bioact. Compat. Polym. 8, 236 (1983).
25. E. Chiellini, R. Solaro, S. D'Antone, and L. Bemporad, Eur. Patent EP 0486445, (to Istituto Sierovaccinogeno Italiano) (1992).
26. S. Tsuchiya, Y. Aramaki, T. Hara, K. Hosoi, and A. Okada, Biopharm. Drug Dispos. 7, 549 (1986).
27. J. Cowdall, J. Davies, M. Roberts, A. Carlsson, R. Solaro, G. Mazzanti, E. E. Chiellini, E. Chiellini, and E. Söderlind (to Istituto Sierovaccinogeno Italiano I.S.I. S.P.A., Italy), PCT Int. Appl., WO9902131 (1999).
28. J. Cowdall, J. Davies, M. Roberts, A. Carlsson, R. Solaro, G. Mazzanti, E. E. Chiellini, E. Chiellini and E. Söderlind (to Istituto Sierovaccinogeno Italiano I.S.I. S.P.A., Italy), PCT Int. Appl., WO 9902135 (1999).
29. J. L. Cleland and A. J. S. Jones, PCT US/94/01666-WO94/19020 (1994).
30. V. H. Lee (ed.), in Peptide and Protein Drug Delivery, Dekker, New York (1991), p. 1.
31. Y. Aramaki, A. Inaba, and S. Tsuchiya, Biopharm. Drug. Dispos. 6, 389 (1985).
32. M. Dubois, K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith, Anal. Chem. 28, 350 (1956).
33. H. Yoshioka, T. Ohmura, M. Hasegawa, S. Hirota, M. Makino, and M. Kamiya, J. Pharm. Sci. 82, 273 (1993).
34. A. L. Schawartz, S. E. Fridovich, and H. F. Lodish, J. Biol. Chem. 257, 4320 (1982).
35. J. T. Chance, S. A. Larsen, V. Pope, J. W. Measel, and D. L. Cox, Cytometry 22, 232 (1995).
36. P. Van Der Smissen, T. Vael, P. J. Courtoy, and P. Baudhuin, Eur. J. Cell Biol. 60, 122 (1993).